ClinicalTrials.gg
RecruitingNCT06197035Updated Apr 1, 2024

The Coping With and Caring for Infants With Special Needs Intervention in Down Syndrome Infants

An interventional study of Coping With and Caring for Infants With Special Needs and Standard Physiotherapy in Down Syndrome, Family and Physical Disability, sponsored by University of Seville. Recruiting at 1 site in Spain. Open to participants aged 1 Month to 18 Months. Per ClinicalTrials.gov, last updated 2024-04-01.

Sponsored by University of Seville · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
1 Month to 18 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Down Syndrome with a site in Spain — 9 open to participants now, 9 under way, 1 of them phase 3. Down Syndrome · Spain.

Planned enrollment
11th of 18
40 · median 58
Started
2024
with 3 others
No phase
10 of 36
2 open now
Registered
27th of 36
by date
Lead sponsor
4 of 36
University of Seville

Among the 36 studies in Down Syndrome with a site in Spain, this one is the 11th largest by planned enrollment of the 18 interventional ones that give a count, is one of 4 that started in 2024, is one of 10 with no phase, and was the 27th registered.

Down Syndrome

439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.

Browse Down Syndrome studies →

Open to participants now

9 of the 36 studies in Down Syndrome with a site in Spain are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.

This study: 1 Month to 18 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Down Syndrome with a site in Spain, or all of them as a file.
02

Study summary

The objective is to compare the impact of standard infant physical therapy and the family-centered program, Coping with and Caring for Infants with Special Needs (COPCA), on infants born with Down syndrome. This is a randomized controlled trial that will be carried out in the patients' homes and outpatient settings in Spain between January 2024 and March 2024. An evaluation battery will be used that includes child and family outcomes and video analysis of therapy sessions.

The Infant Motor profile will be the primary outcome instrument.

03

Conditions studied

  • Down Syndrome
  • Family
  • Physical Disability

Browse trials for

04

Who can participate

Ages eligible
1 Month to 18 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Babies with Down syndrome
  • Families involved in Pediatric Physical Therapy

Exclusion criteria

Exclusion Criteria:

  • Other associated developmental disorders
  • To not speak Spanish
  • Do not sign
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    COPCA (Coping With and Caring for Infants With Special Needs) Intervention

    The intervention will be delivered by COPCA coaches who follow the programme's theoretical and practical principles. Caregivers learnt how to stimulate their infant's development by challenging their motor behaviour with trial and error experiences. This aim to empower the caregivers' competencies to stimulate the infant's daily development, by increasing their motor repertoire. and enhancing their capacity to adapt movements to situations.

    Procedure: Coping With and Caring for Infants With Special Needs

  • Active comparator
    Standard physiotherapy

    Standard care will be based on what paediatric physiotherapists generally assume to be useful to promote the development of infants with special needs. Standard care is heterogeneous and eclectic, uses parent training and often includes components of neurodevelopmental treatment with hands-on techniques.

    Procedure: Standard Physiotherapy

Interventions

  • ProcedureCoping With and Caring for Infants With Special Needs

    The early intervention programme for infants and young children focuses on the active inclusion of the whole family. The coaching of parents is a central component. Parents learn how they can independently and optimally support their child's development as part of the child's everyday life. The programme was developed at the beginning of the 2000s in the Netherlands by child physiotherapist Tineke Dirks and professor of developmental neurology Mijna Hadders-Algra.

  • ProcedureStandard Physiotherapy

    Pediatric physiotherapy techniques aimed at improving the development of the baby and young child from manual therapy tools, or baby management.

06

What researchers measure

Primary outcomes

  1. Motor Development

    INFANT MOTOR PROFILE Results achieved between the 10% and 90% percentiles indicate adequate motor development. Results between the 5% and 10% percentiles indicate a risk for delays or problems in gross motor development.

    Time frame: 3-6-18 months.

Secondary outcomes

  1. Family empowerment

    Family Empowerment Scale There are 28 items to be answered by the family with these options: 1= Strongly Agree' 2= Agree' 3= Disagree' 4= Strongly Disagree. The higher the score, the greater the empowerment.

    Time frame: 3-6-18 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The publication of the results of this research is planned.

Supporting information: Study protocol

Time frame: In 6 months

Access criteria: Asking t the investigator

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Oct 2024, 7 months after the start.

Of 163 non-industry interventional studies with no phase under Down Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 33. This study's planned 7 months is below that.

Counting every sponsor, half of 165 studies reached it within 11 months; a quarter within 3 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 25, 2023
First posted
Jan 9, 2024
StartActual
Mar 10, 2024
Primary completionEst.
Oct 20, 2024
CompletionEst.
Oct 20, 2024
Last update
Apr 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06197035
Responsible party
Elena Piñero Pinto (Professor, University of Seville) — Principal investigator
First posted
Jan 9, 2024
Start date
Mar 10, 2024
Primary completion
Oct 20, 2024 (estimated)
Completion
Oct 20, 2024 (estimated)
Last update
Apr 1, 2024

Study contacts

Elena Pinero-Pinto, PhD
Contact
epinero@us.es
+34655108763
Elena Pinero-Pinto, PhD
study director · University of Seville

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion